Health Canada
www.hc-sc.gc.ca
Home > Health Concerns > Reports & Publications > Controlled Substances & Precursor Chemicals > Report on the Review of Sales Transactions for Oxycodone-based Products in Atlantic Canada
Report on the Review of Sales Transactions for Oxycodone-based Products in Atlantic Canada (Retail Pharmacies only)
7.2 Volume of transactions of products by prime medical specialty
7.2.1 Regional
This section presents a table showing transactions by product for those prime medical specialties that generate 95% of the regional volume of transactions as presented in Table 3. Please refer to Appendix 2 for the meaning of prime medical specialty acronyms.
Table 9: Volume of transactions of products by prime medical specialty, Atlantic Canada
| Atlantic Canada |
| Rank |
P. SPC |
Endocet |
Percocet |
Ratio - Oxycocet |
Oxycontin - Srt 20 |
Oxycontin - Srt 40 |
Oxycontin - Srt 10 |
Pms - Oxy - Acet |
Oxycontin - Srt 80 |
Oxy - Ir 10 |
Oxy - Ir 20 |
Oxy - Ir 5 |
Endodan |
Percocet - Demi |
Supeudol 10 |
Percodan |
Ratio - Oxycodan |
Supeudol 5 |
Percodan - Demi |
Total |
| 1 |
GP |
19,582 |
6,274 |
4,934 |
4,629 |
3,500 |
3,244 |
1,868 |
1,303 |
929 |
792 |
683 |
619 |
503 |
367 |
251 |
151 |
100 |
1 |
49,730 |
| 2 |
FM |
14,534 |
1,942 |
3,653 |
3,099 |
2,011 |
2,025 |
506 |
1,019 |
510 |
230 |
333 |
224 |
221 |
74 |
26 |
21 |
54 |
1 |
30,483 |
| 3 |
Blank |
1,628 |
183 |
586 |
142 |
153 |
102 |
37 |
64 |
7 |
5 |
19 |
54 |
45 |
|
10 |
10 |
|
|
3,045 |
| 4 |
ORS |
1,392 |
85 |
338 |
159 |
25 |
98 |
20 |
5 |
8 |
1 |
43 |
|
5 |
|
|
|
|
|
2,179 |
| 5 |
ANE |
657 |
38 |
15 |
357 |
345 |
145 |
5 |
11 |
99 |
11 |
40 |
43 |
5 |
|
7 |
|
|
1 |
1,779 |
| 6 |
DDS |
437 |
33 |
417 |
1 |
1 |
28 |
15 |
|
|
|
|
21 |
67 |
|
2 |
|
|
|
1,022 |
| |
Total |
38,230 |
8,555 |
9,943 |
8,387 |
6,035 |
5,642 |
2,451 |
2,402 |
1,553 |
1,039 |
1,118 |
961 |
846 |
441 |
296 |
182 |
154 |
3 |
88,238 |
7.2.2 Provincial
This section presents tables showing transactions by product for those prime medical specialties that generate 95% of the provincial volume of transactions as presented in Table 3.
Table 10: Volume of transactions of products by prime medical specialty, New Brunswick
| New Brunswick |
| Rank |
P. SPC |
Endocet |
Oxycontin-Srt 20 |
Oxycontin-Srt 10 |
Oxycontin-Srt 40 |
Ratio-Oxycocet |
Oxycontin-Srt 80 |
Oxy-Ir 10 |
Oxy-Ir 5 |
Percocet-Demi |
Percocet |
Oxy-Ir 20 |
Endodan |
Supeudol 10 |
Ratio-Oxycodan |
Supeudol 5 |
Percodan |
Percodan-Demi |
Pms-Oxy-Acet |
Total |
| 1 |
FM |
11,164 |
1,634 |
1,200 |
1,139 |
809 |
522 |
260 |
191 |
177 |
167 |
93 |
73 |
16 |
11 |
9 |
1 |
1 |
1 |
17,468 |
| 2 |
GP |
10,448 |
1,614 |
1,200 |
1,208 |
796 |
505 |
316 |
271 |
200 |
231 |
203 |
152 |
28 |
27 |
14 |
21 |
1 |
|
17,235 |
| 3 |
Blank |
1,204 |
88 |
58 |
131 |
69 |
33 |
5 |
11 |
21 |
21 |
|
29 |
|
1 |
|
1 |
|
|
1,672 |
| 4 |
ORS |
1,303 |
77 |
64 |
17 |
34 |
|
8 |
40 |
5 |
11 |
|
|
|
|
|
|
|
|
1,559 |
| 5 |
RES |
247 |
16 |
3 |
15 |
3 |
1 |
|
2 |
4 |
1 |
|
|
|
|
|
|
|
|
292 |
| 6 |
GSU |
248 |
1 |
12 |
1 |
8 |
|
|
|
5 |
1 |
|
|
|
|
|
|
|
|
276 |
| |
Total |
24,614 |
3,430 |
2,537 |
2,511 |
1,719 |
1,061 |
589 |
515 |
412 |
432 |
296 |
254 |
44 |
39 |
23 |
23 |
2 |
1 |
38,502 |
Table 11: Volume of transactions of products by prime medical specialty, Nova Scotia
| Nova Scotia |
| Rank |
P. SPC |
Endocet |
Oxycontin-Srt 20 |
Oxycontin-Srt 40 |
Oxycontin-Srt 10 |
Ratio-Oxycocet |
Endodan |
Percocet |
Oxy-Ir 10 |
Oxycontin-Srt 80 |
Oxy-Ir 20 |
Percocet-Demi |
Supeudol 10 |
Oxy-Ir 5 |
Supeudol 5 |
Percodan |
Ratio-Oxycodan |
Total |
| 1 |
GP |
9,047 |
1,309 |
990 |
982 |
716 |
467 |
407 |
367 |
328 |
290 |
282 |
256 |
247 |
77 |
44 |
42 |
15,851 |
| 2 |
FM |
3,304 |
545 |
296 |
386 |
257 |
151 |
103 |
166 |
104 |
55 |
44 |
41 |
102 |
10 |
3 |
|
5,567 |
| 3 |
ANE |
604 |
334 |
330 |
100 |
13 |
43 |
24 |
91 |
8 |
10 |
5 |
|
34 |
|
6 |
|
1,602 |
| 4 |
Blank |
397 |
12 |
5 |
14 |
29 |
25 |
5 |
1 |
1 |
1 |
21 |
|
5 |
|
8 |
2 |
526 |
| |
total |
13,352 |
2,200 |
1,621 |
1,482 |
1,015 |
686 |
539 |
625 |
441 |
356 |
352 |
297 |
388 |
87 |
61 |
44 |
23,546 |
Table 12: Volume of transactions of products by prime medical specialty, Newfoundland and Labrador
| Newfoundland and Labrador |
| Rank |
P. SPC |
Percocet |
Pms-Oxyc-Acet |
Oxycontin-Srt 20 |
Ratio-Oxycocet |
Oxycontin-Srt 40 |
Oxycontin-Srt 10 |
Oxycontin-Srt 80 |
Oxy-Ir 20 |
Oxy-Ir 10 |
Percodan |
Oxy-Ir 5 |
Supeudol 10 |
Percocet-Demi |
Ratio-Oxycodan |
Supeudol 5 |
Endocet |
Percodan-Demi |
Total |
| 1 |
GP |
5,605 |
1,868 |
1,401 |
1,300 |
1,195 |
896 |
447 |
298 |
220 |
186 |
139 |
81 |
21 |
17 |
8 |
4 |
|
13,686 |
| 2 |
FM |
1,654 |
505 |
519 |
451 |
441 |
238 |
320 |
82 |
72 |
18 |
18 |
17 |
|
2 |
35 |
7 |
|
4,379 |
| |
Total |
7,259 |
2,373 |
1,920 |
1,751 |
1,636 |
1,134 |
767 |
380 |
292 |
204 |
157 |
98 |
21 |
19 |
43 |
11 |
0 |
18,065 |
Table 13: Volume of transactions of products by prime medical specialty, Prince Edward Island
| Prince Edward Island |
| Rank |
P. SPC |
Ratio-Oxycocet |
Oxycontin-Srt 20 |
Oxycontin-Srt 10 |
Oxycontin-Srt 40 |
Oxycontin-Srt 80 |
Endocet |
Oxy-Ir 5 |
Percocet |
Oxy-Ir 10 |
Ratio-Oxycodan |
Percodan |
Supeudol 10 |
Supeudol 5 |
Oxy-Ir 20 |
Percocet-Demi |
Total |
| 1 |
FM |
2,136 |
401 |
201 |
135 |
73 |
59 |
22 |
18 |
12 |
8 |
4 |
|
|
|
|
3,069 |
| 2 |
GP |
2,122 |
305 |
166 |
107 |
23 |
83 |
26 |
31 |
26 |
65 |
|
2 |
1 |
1 |
|
2,958 |
| 3 |
Blank |
459 |
32 |
22 |
10 |
14 |
27 |
1 |
5 |
1 |
5 |
|
|
|
|
3 |
579 |
| 4 |
IM |
522 |
20 |
|
|
|
6 |
|
|
1 |
8 |
|
|
|
|
|
557 |
| 5 |
DDS |
405 |
|
|
|
|
21 |
|
8 |
|
|
|
|
|
|
1 |
435 |
| 6 |
ORS |
292 |
71 |
12 |
6 |
4 |
11 |
1 |
7 |
|
|
|
|
|
|
|
404 |
| |
Total |
5,936 |
829 |
401 |
258 |
114 |
207 |
50 |
69 |
40 |
86 |
4 |
2 |
1 |
1 |
4 |
8,002 |